Maury A. Audet

Array ( [id] => 10932168 [patent_doc_number] => 20140335189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'INTESTINAL PEPTIDE TARGETING LIGANDS' [patent_app_type] => utility [patent_app_number] => 14/445541 [patent_app_country] => US [patent_app_date] => 2014-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8974 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14445541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642201 [patent_doc_number] => 09663558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Mutated immunoglobulin-binding polypeptides' [patent_app_type] => utility [patent_app_number] => 14/904077 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6586 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10813695 [patent_doc_number] => 20160159855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'MUTATED IMMUNOGLOBULIN-BINDING POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/903837 [patent_app_country] => US [patent_app_date] => 2014-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6845 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10805289 [patent_doc_number] => 20160151447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE' [patent_app_type] => utility [patent_app_number] => 14/903010 [patent_app_country] => US [patent_app_date] => 2014-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16383 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912810 [patent_doc_number] => 20140315829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Compositions And Methods For Enhancing Sialic Acid Levels In Tissue' [patent_app_type] => utility [patent_app_number] => 14/322416 [patent_app_country] => US [patent_app_date] => 2014-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9085 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14322416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10769045 [patent_doc_number] => 20160115200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'New Use for JNK Inhibitor Molecules for Treatment of Various Diseases' [patent_app_type] => utility [patent_app_number] => 14/890859 [patent_app_country] => US [patent_app_date] => 2014-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 34247 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12247330 [patent_doc_number] => 09920096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Bradykinin receptor modulators and use thereof' [patent_app_type] => utility [patent_app_number] => 14/392278 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 9385 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15694383 [patent_doc_number] => 10603352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-31 [patent_title] => Formulations of hepalatide [patent_app_type] => utility [patent_app_number] => 14/901249 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 14917 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14901249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9932104 [patent_doc_number] => 20150080297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'PEDIATRIC FIBER MIXTURE' [patent_app_type] => utility [patent_app_number] => 14/312506 [patent_app_country] => US [patent_app_date] => 2014-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9199 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9772481 [patent_doc_number] => 20140296143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'Angiotensin-(1-7) As A Chemoprevention Agent' [patent_app_type] => utility [patent_app_number] => 14/305399 [patent_app_country] => US [patent_app_date] => 2014-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 30188 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14305399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10946916 [patent_doc_number] => 20140349937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'METHODS FOR TREATING BENIGN PROSTATIC HYPERTROPHY (BPH)' [patent_app_type] => utility [patent_app_number] => 14/299596 [patent_app_country] => US [patent_app_date] => 2014-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19268 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14299596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10767841 [patent_doc_number] => 20160113997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'BETA-CASEIN A2 AND PREVENTION OF INFLAMMATION OF THE BOWEL' [patent_app_type] => utility [patent_app_number] => 14/894711 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8282 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14894711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10634540 [patent_doc_number] => 09352027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Albumin-free factor VIII formulations' [patent_app_type] => utility [patent_app_number] => 14/286391 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7584 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14286391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919285 [patent_doc_number] => 20140322302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'THERAPEUTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/274735 [patent_app_country] => US [patent_app_date] => 2014-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 64288 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14274735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657534 [patent_doc_number] => 20140228539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'SEPARATION OF ACETYLATED PROTEINS FROM UNACETYLATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/256492 [patent_app_country] => US [patent_app_date] => 2014-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4844 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14256492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799524 [patent_doc_number] => 20150011467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'OXYNTOMODULIN ANALOGUES AND THEIR EFFECTS ON FEEDING BEHAVIOUR' [patent_app_type] => utility [patent_app_number] => 14/249535 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 402 [patent_figures_cnt] => 402 [patent_no_of_words] => 42930 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 71 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14249535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10627613 [patent_doc_number] => 09345750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Long-acting formulations of insulin' [patent_app_type] => utility [patent_app_number] => 14/220562 [patent_app_country] => US [patent_app_date] => 2014-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 30334 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14220562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9917713 [patent_doc_number] => 20150072918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'PROTEIN PURIFICATION' [patent_app_type] => utility [patent_app_number] => 14/218445 [patent_app_country] => US [patent_app_date] => 2014-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14372 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14218445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025129 [patent_doc_number] => 20160222084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies' [patent_app_type] => utility [patent_app_number] => 14/776855 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14889 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628705 [patent_doc_number] => 09346850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Method of producing peptide' [patent_app_type] => utility [patent_app_number] => 14/204074 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25012 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14204074 [rel_patent_id] =>[rel_patent_doc_number] =>)